Skip to main navigation Skip to search Skip to main content

Pathway-guided deep neural network toward interpretable and predictive modeling of drug sensitivity

  • Lei Deng
  • , Yideng Cai
  • , Wenhao Zhang
  • , Wenyi Yang
  • , Bo Gao*
  • , Hui Liu*
  • *Corresponding author for this work
  • School of Computer Science and Engineering
  • Changzhou University
  • Affiliated Changzhou No.2 People’s Hospital of Nanjing Medical University

Research output: Contribution to journalArticlepeer-review

Abstract

To efficiently save cost and reduce risk in drug research and development, there is a pressing demand to develop in silico methods to predict drug sensitivity to cancer cells. With the exponentially increasing number of multi-omics data derived from high-throughput techniques, machine learning-based methods have been applied to the prediction of drug sensitivities. However, these methods have drawbacks either in the interpretability of the mechanism of drug action or limited performance in modeling drug sensitivity. In this paper, we presented a pathway-guided deep neural network (DNN) model to predict the drug sensitivity in cancer cells. Biological pathways describe a group of molecules in a cell that collaborates to control various biological functions like cell proliferation and death, thereby abnormal function of pathways can result in disease. To take advantage of the excellent predictive ability of DNN and the biological knowledge of pathways, we reshaped the canonical DNN structure by incorporating a layer of pathway nodes and their connections to input gene nodes, which makes the DNN model more interpretable and predictive compared to canonical DNN. We have conducted extensive performance evaluations on multiple independent drug sensitivity data sets and demonstrated that our model significantly outperformed the canonical DNN model and eight other classical regression models. Most importantly, we observed a remarkable activity decrease in disease-related pathway nodes during forward propagation upon inputs of drug targets, which implicitly corresponds to the inhibition effect of disease-related pathways induced by drug treatment on cancer cells. Our empirical experiments showed that our method achieves pharmacological interpretability and predictive ability in modeling drug sensitivity in cancer cells. The web server, the processed data sets, and source codes for reproducing our work are available at http://pathdnn.denglab.org.

Original languageEnglish
Pages (from-to)4497-4505
Number of pages9
JournalJournal of Chemical Information and Modeling
Volume60
Issue number10
DOIs
StatePublished - 26 Oct 2020
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Pathway-guided deep neural network toward interpretable and predictive modeling of drug sensitivity'. Together they form a unique fingerprint.

Cite this